Ogawa Y, Lei P S, Kovác P
NIDDK, National Institutes of Health, Bethesda, MD 20892-0815, USA.
Carbohydr Res. 1996 Oct 31;293(2):173-94. doi: 10.1016/0008-6215(96)00202-9.
The title substances were prepared from intermediate, fully acetylated alpha-trimethylsilylethyl (SE) glycosides. The latter were assembled in a blockwise manner, using as the glycosyl donor the alpha-glycosyl chloride of a disaccharide bearing two 4-azido-4-deoxy functions. Next, the azido groups in the assembled hexasaccharides were converted to the corresponding amines, and these were acylated with 4-O-benzyl-3-deoxy-L-glycero-tetronic acid in the presence of a water-soluble carbodiimide. The SE glycosides were then transformed to glycosyl imidates, and these were coupled with methyl 6-hydroxyhexanoate or methyl 2-(2-hydroxyethylthio) propionate. The aglycons in the glycosides thus obtained were then converted to the corresponding carboxylic acids or acyl hydrazides. Such compounds are suitable for linking to proteins to obtain neoglycoproteins.
标题化合物由中间体、全乙酰化的α-三甲基硅基乙基(SE)糖苷制备。后者以逐步方式组装,使用带有两个4-叠氮基-4-脱氧官能团的二糖的α-糖基氯作为糖基供体。接下来,将组装好的六糖中的叠氮基转化为相应的胺,并在水溶性碳二亚胺存在下用4-O-苄基-3-脱氧-L-甘油-四酮酸对其进行酰化。然后将SE糖苷转化为糖基亚氨酸酯,并将其与6-羟基己酸甲酯或2-(2-羟乙基硫基)丙酸甲酯偶联。然后将由此得到的糖苷中的苷元转化为相应的羧酸或酰肼。这类化合物适用于与蛋白质连接以获得新糖蛋白。